Testing

The paperwork behind the vial.

Compounded medications should come with receipts. Here is how certificates of analysis and stability studies work — and a current sample from the licensed pharmacy network that fills Peptivik prescriptions.

Certificate of Analysis (COA)A lab report tied to one specific production lot. It documents what testing found for that exact batch — typically identity and potency, plus sterility-related testing where applicable — before it is dispensed.
Stability studyTesting of how a preparation holds up over time and outside refrigeration — the "what if the box sits on a hot porch" question — expressed as measured temperature ranges and durations, not guesses.
Lot numberThe tracing key printed on the vial label. It connects the vial in your hand to the COA for the batch it came from — which is exactly what you can ask us for.
What the tests cover
IdentityConfirms the tested lot contains the compound the label names.
PotencyVerifies the tested lot delivers the strength stated on its label.
SterilityConfirms no detectable microbial growth in the tested sample.
EndotoxinScreens the tested lot below USP limits for bacterial endotoxins.

This testing is performed by the licensed pharmacies and their testing partners, not by Peptivik, and is documented per lot in certificates of analysis. Which panels a given certificate reports varies by preparation — the certificate itself is the record.

Published lots — current sample

Sampled from the dispensing network’s published COA library on November 11, 2026. Lots rotate as batches are produced and dispensed — these are examples of the documentation standard, not an inventory list, and not a claim about which lot fills a given prescription. Sermorelin, NAD+ and PT-141 have no current-dated lot in the network’s published library right now; their lots will appear here when the pharmacy publishes them.

Glutathione
LotStrengthVialExpiresCompounding pharmacy
PGR-07102026-01200 mgNot listedJan 5, 2027PGRrx
PGR-30092026-01200 mgNot listedDec 29, 2026PGRrx
Semaglutide
Current published semaglutide lots are co-formulations (with B12 or glycine), as listed by the testing pharmacy.
LotStrengthVialExpiresCompounding pharmacy
HT-142.5 mg / 0.5 mg (with B12)5 mLApr 15, 2027Hyalo Technologies
HT-152.5 mg / 0.5 mg (with B12)2 mLApr 14, 2027Hyalo Technologies
HT-162.5 mg / 5 mg (with glycine)5 mLApr 13, 2027Hyalo Technologies
HT-172.5 mg / 5 mg (with glycine)2 mLApr 12, 2027Hyalo Technologies
05272026023.125 mg / 5 mg per mL (with glycine)4 mLNov 27, 2026Vital Rx
05272026043.125 mg / 0.5 mg per mL (with B12)4 mLNov 27, 2026Vital Rx
05272026052.5 mg / 0.5 mg per mL (with B12)2 mLNov 27, 2026Vital Rx
Tirzepatide
Published tirzepatide lots include co-formulations (with methylcobalamin or glycine), as listed by the testing pharmacies.
LotStrengthVialExpiresCompounding pharmacy
PGR-15102026-0118 mg/mL4 mLApr 13, 2027PGRrx
PGR-14102026-0118 mg/mL4 mLApr 12, 2027PGRrx
PGR-13102026-0118 mg/mL4 mLApr 11, 2027PGRrx
PGR-05062026-0118 mg/mL4 mLDec 2, 2026PGRrx
PGR-04062026-0118 mg/mL4 mLDec 1, 2026PGRrx
PGR-02062026-0118 mg/mL4 mLNov 29, 2026PGRrx
PGR-01062026-0118 mg/mL4 mLNov 28, 2026PGRrx
AP-20264418 mg/mL2 mLNov 26, 2026Apothecary
AP-20264318 mg/mL2 mLNov 25, 2026Apothecary
AP-20264118 mg/mL4 mLNov 22, 2026Apothecary
HT-2672 mg4 mLJun 9, 2027Hyalo Technologies
HT-2736 mg2 mLJun 4, 2027Hyalo Technologies
HT-2436 mg2 mLMay 21, 2027Hyalo Technologies
HT-2372 mg4 mLMay 19, 2027Hyalo Technologies
HT-2236 mg2 mLMay 14, 2027Hyalo Technologies
HT-2172 mg4 mLMay 12, 2027Hyalo Technologies
HT-2018 mg1 mLMay 8, 2027Hyalo Technologies
HT-1972 mg4 mLMay 2, 2027Hyalo Technologies
HT-1836 mg2 mLApr 29, 2027Hyalo Technologies
HT-1017 mg / 0.5 mg (with methylcobalamin)4 mLApr 17, 2027Hyalo Technologies
HT-1117 mg / 0.5 mg (with methylcobalamin)2 mLApr 16, 2027Hyalo Technologies
HT-1217 mg / 5 mg (with glycine)4 mLApr 16, 2027Hyalo Technologies
HT-1317 mg / 5 mg (with glycine)2 mLApr 15, 2027Hyalo Technologies
052820260717 mg / 5 mg per mL (with glycine)2 mLNov 28, 2026Vital Rx
052720260617 mg / 5 mg per mL (with glycine)4 mLNov 27, 2026Vital Rx
Shipping & temperature

The network also publishes temperature-excursion studies — measured answers to what happens if a shipment spends time outside refrigeration. Published findings, as stated by the testing pharmacies:

StudyPublished findingDated
Tirzepatide — room temperatureStable for 4 days at ambient temperature.Mar 2026
Tirzepatide — elevated temperatureStable for 2 days at 40°C (104°F) — studied by two independent compounders.May 2026
Tirzepatide & semaglutide co-formulations (Hyalo)Stable for 4 days at 60°C (140°F).2026–2027 lots
Semaglutide/glycine — temperature excursion, 0–60°CMinor degradation observed only at 60°C by day 4.Aug 2025
NAD+ — room temperatureStable for 45 days at 25°C (77°F).Sep 2025

Excursion studies describe tested shipping scenarios — they are not storage instructions. Always follow the storage and handling directions on your medication label.

Check your own vial

Every vial dispensed to you carries a lot number on its label. Email it to support@peptivik.com and we’ll request the certificate of analysis for that exact lot from the dispensing pharmacy.

Prescriptions through Peptivik are filled by state-licensed compounding pharmacies in our medical partner’s dispensing network; the pharmacy that fills a given prescription varies by state and product. Certificates of analysis and stability studies are documents produced and published by those pharmacies and their testing partners, reproduced here for education — Peptivik does not manufacture, compound, test, or handle medication. This page is educational and is not medical advice.

Start today

Begin with a licensed domestic provider consultation.

Choose your protocol